New treatment option for Delirium
Official title VR Interventions to Reduce the Prevalence of Delirium in ICU Patients
ClinicalTrials.gov ID: NCT05525702
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn the effect of Virtual Reality Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is: Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Mechanical ventilation duration is expected to be greater than 24 hours;
- ICU stay duration is expected to be greater than 72 hours;
- Age is 18 years or older, with no upper age limit;
- Language: Chinese.
You likely can't join if
- Severe visual or auditory impairments (diplopia, low vision due to macular degeneration, retinopathy; severe hearing loss or deafness);
- Cognitive and consciousness disturbances prior to ICU admission;
- Severe motion sickness;
- Head trauma or surgery that prevents the wearing of equipment;
- A history of long-term use of antipsychotic and/or benzodiazepine medications.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.